Now, I am heartened to read about the advances Yale has made in accommodating the disabled, both from a physical and technological standpoint, as well as from a humanistic one. Thank you for your continued efforts to make Yale Medicine interesting and fresh. However, the glossy paper that is used in printing the magazine makes it almost impossible to read. Since I actually treasure each issue of Yale Medicine and am sure others must be affected as I am, I hope you can find a solution to this devastating problem. However, the 30-day limit has been found to be unrealistic, especially when diagnosis and treatment are delayed.
Nationwide evidence supports longer-term therapy for many patients.
The study described in the article does not address several questions, including elapsed time between symptoms and diagnosis. The difficulties presented by Lyme disease include uncertainties about test results with resultant delayed diagnosis, penetration of the spirochete into cells, the changing forms of Borrelia burgdorferi , and its ability to cloak itself in DNA of the host. Evidence of long-term disability from inadequate treatment of Lyme disease is documented. And because of the potential for serious disability, I believe CDC treatment guidelines need to be re-examined. I would also like to see Yale involved in the development of more effective antibiotics for Lyme disease.